Tilray Medical Receives Italy’s First Authorization From the Ministry of Health to Distribute Medical Cannabis Flower for Therapeutic Use
7 Articles
7 Articles


Tilray Medical Receives Italy’s First Authorization from the Ministry of Health to Distribute Medical Cannabis Flower for Therapeutic Use
SAVONA, Italy, June 24, 2025 (GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global...
Tilray Becomes First Company Authorized to Distribute Branded Medical Marijuana Flower in Italy
The Marijuana Herald - Marijuana news and information Tilray Medical has made history as the first company to receive formal authorization from the Italian Ministry of Health to import and distribute its branded medical marijuana flower products across Italy. Beginning this month, Tilray-branded flower is available for distribution to pharmacies nationwide through its subsidiary, FL Group. Three products have been approved for therapeutic use: T…
Tilray Medical Receives Italy’s Ministry of Health's First
SAVONA, Italy — Tilray Medical, a division of Tilray Brands Inc., through its wholly-owned subsidiary, FL Group, became the first company in Italy to receive official authorization from the Ministero della Salute (Italian Ministry of Health) to import and distribute proprietary Tilray Medical-branded medical cannabis flower for therapeutic use. Beginning in June, the following Tilray Medical products are approved for therapeutic use in Italy and…
Tilray sets medical cannabis milestone in Italy
Tilray Medical, a division of Tilray Brands (TSX:TLRY), has become the first company to receive Italian authorization to distribute medical cannabis flower for therapeutic use Tilray is a global consumer packaged goods company active in cannabis, beverage, wellness and entertainment Tilray stock has given back 78.17 per cent year-over-year and 97.46 per cent since 2021 Tilray Medical, a division of major cannabis player Tilray Brands (TSX:TLRY),…
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium